Tests:HbA1c (POCT): Difference between revisions
- Department
- Point of care
Tests:HbA1c (POCT)
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
|'''Synonyms''' | |'''Synonyms''' | ||
|HbA1c whole blood (POCT) | |HbA1c whole blood (POCT) | ||
glycated haemoglobin | |||
HBA | |||
|- | |- | ||
|'''Availability''' | |'''Availability''' | ||
|Cobas b101 HbA1c devices are available at both Taranaki Base and Hawera hospital. | |Cobas b101 HbA1c devices are available at both Taranaki Base and Hawera hospital. | ||
|- | |- | ||
|'''Turnaround Time''' | |'''Turnaround Time''' | ||
| | |6 minutes from placing cartridge into analyser with patients' blood sample | ||
|- | |- | ||
|'''Stability – Add test''' | |'''Stability – Add test''' | ||
| | |60 seconds once blood sample has been applied to cartridge disc. | ||
EDTA samples within 2 hours from collection | |||
Lithium-Heparin within 8 hours from collection | |||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
| Line 36: | Line 38: | ||
|- | |- | ||
|'''Acceptable''' | |'''Acceptable''' | ||
| | |Purple top (EDTA) or Lithium-Heparin, non-gel (green top) | ||
|- | |- | ||
|'''Unacceptable''' | |'''Unacceptable''' | ||
|Samples | |Samples containing anticoagulants or other additives | ||
Separated samples | Separated samples | ||
|- | |- | ||
|'''Minimum Volume''' | |'''Minimum Volume''' | ||
| | |2µL whole blood | ||
|- | |- | ||
|'''Specimen Collection and Transportation''' | |'''Specimen Collection and Transportation''' | ||
| Line 54: | Line 54: | ||
|- | |- | ||
|'''Test Method''' | |'''Test Method''' | ||
| | |Cobas b101 - ROCHE analyser | ||
|- | |- | ||
|'''Unit of Measurement''' | |'''Unit of Measurement''' | ||
| mmol/ | | mmol/mol | ||
|- | |- | ||
|'''Reference Intervals''' | |'''Reference Intervals''' | ||
| | |Non-diabetic reference interval 20-40 mmol/mol. | ||
Risk of microvascular complications increases exponentially above 55 mmol/mol. | |||
If >/= 50 mmol/mol and not known to have diabetes, a repeat level >/= 50 after an interval supports the diagnosis. | |||
If result is >65 mmol/mol, consider additional action. | |||
|- | |- | ||
|'''Uncertainty of measurement''' | |'''Uncertainty of measurement''' | ||
| Line 66: | Line 71: | ||
|- | |- | ||
|'''Additional Information''' | |'''Additional Information''' | ||
| | |Ranges of measurement 20-130mmol/mol | ||
The presence of some haemoglobin variants may require testing via alternative methods for HbA1c or the laboratory may refer clinician to glucose based criteria for diagnosis and monitoring. | |||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== '''Comments''' == | == '''Comments''' == | ||
|- | |- | ||
| colspan="2" |Quick user guides for testing should be available with the | | colspan="2" |Quick user guides for testing should be available with or near the analysers. | ||
All procedures, worksheets and competency checklist for | All procedures, worksheets and competency checklist for sign-off are available on the intranet to all Health NZ Staff. | ||
|} | |} | ||
{{DocMeta | {{DocMeta | ||
Revision as of 14:17, 1 October 2025
Overview | |
|---|---|
| Department | POCT |
| Test Code | N/A |
| Synonyms | HbA1c whole blood (POCT)
glycated haemoglobin HBA |
| Availability | Cobas b101 HbA1c devices are available at both Taranaki Base and Hawera hospital. |
| Turnaround Time | 6 minutes from placing cartridge into analyser with patients' blood sample |
| Stability – Add test | 60 seconds once blood sample has been applied to cartridge disc.
EDTA samples within 2 hours from collection Lithium-Heparin within 8 hours from collection |
Specimen Requirements | |
| Specimen | Whole Blood |
| Preferred | Finger Stab - Droplet of Whole blood |
| Acceptable | Purple top (EDTA) or Lithium-Heparin, non-gel (green top) |
| Unacceptable | Samples containing anticoagulants or other additives
Separated samples |
| Minimum Volume | 2µL whole blood |
| Specimen Collection and Transportation | Clean and dry patients' hand and wipe away the first drop of blood. |
Test Information | |
| Test Method | Cobas b101 - ROCHE analyser |
| Unit of Measurement | mmol/mol |
| Reference Intervals | Non-diabetic reference interval 20-40 mmol/mol.
Risk of microvascular complications increases exponentially above 55 mmol/mol. If >/= 50 mmol/mol and not known to have diabetes, a repeat level >/= 50 after an interval supports the diagnosis. If result is >65 mmol/mol, consider additional action. |
| Uncertainty of measurement | N/A |
| Additional Information | Ranges of measurement 20-130mmol/mol
The presence of some haemoglobin variants may require testing via alternative methods for HbA1c or the laboratory may refer clinician to glucose based criteria for diagnosis and monitoring. |
Comments | |
| Quick user guides for testing should be available with or near the analysers.
All procedures, worksheets and competency checklist for sign-off are available on the intranet to all Health NZ Staff. | |
| Owner | PChung |
|---|---|
| Last reviewed | 1 Oct 2025 |
| Next review | Overdue, 1 Oct 2026 |